Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA590572
Max Phase: Preclinical
Molecular Formula: C28H20Na4O16S4
Molecular Weight: 744.75
Molecule Type: Small molecule
Associated Items:
ID: ALA590572
Max Phase: Preclinical
Molecular Formula: C28H20Na4O16S4
Molecular Weight: 744.75
Molecule Type: Small molecule
Associated Items:
Synonyms (1): Para-Sulfonatocalix[4]Arene
Synonyms from Alternative Forms(1):
Canonical SMILES: O=S(=O)([O-])c1cc2c(O)c(c1)Cc1cc(S(=O)(=O)[O-])cc(c1O)Cc1cc(S(=O)(=O)[O-])cc(c1O)Cc1cc(S(=O)(=O)[O-])cc(c1O)C2.[Na+].[Na+].[Na+].[Na+]
Standard InChI: InChI=1S/C28H24O16S4.4Na/c29-25-13-1-14-6-22(46(36,37)38)8-16(26(14)30)3-18-10-24(48(42,43)44)12-20(28(18)32)4-19-11-23(47(39,40)41)9-17(27(19)31)2-15(25)7-21(5-13)45(33,34)35;;;;/h5-12,29-32H,1-4H2,(H,33,34,35)(H,36,37,38)(H,39,40,41)(H,42,43,44);;;;/q;4*+1/p-4
Standard InChI Key: WCSKZSCSZGMBAN-UHFFFAOYSA-J
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 744.75 | Molecular Weight (Monoisotopic): 743.9947 | AlogP: 2.17 | #Rotatable Bonds: 4 |
Polar Surface Area: 298.40 | Molecular Species: ACID | HBA: 12 | HBD: 8 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: -3.16 | CX Basic pKa: | CX LogP: 3.88 | CX LogD: -5.67 |
Aromatic Rings: 4 | Heavy Atoms: 48 | QED Weighted: 0.12 | Np Likeness Score: 0.01 |
1. Mourer M, Psychogios N, Laumond G, Aubertin AM, Regnouf-de-Vains JB.. (2010) Synthesis and anti-HIV evaluation of water-soluble calixarene-based bithiazolyl podands., 18 (1): [PMID:19944610] [10.1016/j.bmc.2009.11.016] |
2. Mourer M, Massimba Dibama H, Constant P, Daffé M, Regnouf-de-Vains JB.. (2012) Anti-mycobacterial activities of some cationic and anionic calix[4]arene derivatives., 20 (6): [PMID:22361273] [10.1016/j.bmc.2012.01.041] |
3. Tabet S, Douglas SF, Daze KD, Garnett GA, Allen KJ, Abrioux EM, Quon TT, Wulff JE, Hof F.. (2013) Synthetic trimethyllysine receptors that bind histone 3, trimethyllysine 27 (H3K27me3) and disrupt its interaction with the epigenetic reader protein CBX7., 21 (22): [PMID:24100156] [10.1016/j.bmc.2013.09.024] |
4. (2018) Small molecule antagonists of dusp5 and methods of use, |
Source(2):